JP Morgan Chase’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $439K | Sell |
|
|||||
|
2025
Q2 | $575K | Buy |
|
|||||
|
2025
Q1 | $543K | Buy |
|
|||||
|
2024
Q4 | $582K | Sell |
|
|||||
|
2024
Q3 | $1.53M | Buy |
|
|||||
|
2024
Q2 | $768K | Buy |
|
|||||
|
2024
Q1 | $505K | Sell |
|
|||||
|
2023
Q4 | $495K | Sell |
|
|||||
|
2023
Q3 | $416K | Buy |
|
|||||
|
2023
Q2 | $528K | Buy |
|
|||||
|
2023
Q1 | $317K | Sell |
|
|||||
|
2022
Q4 | $979K | Buy |
|
|||||
|
2022
Q3 | $368K | Sell |
|
|||||
|
2022
Q2 | $1.64M | Buy |
|
|||||
|
2022
Q1 | $1.69M | Buy |
|
|||||
|
2021
Q4 | $2.6M | Buy |
|
|||||
|
2021
Q3 | $1.74M | Buy |
|
|||||
|
2021
Q2 | $765K | Buy |
|
|||||
|
2021
Q1 | $370K | Buy |
|
|||||
|
2020
Q4 | $172K | Buy |
|
|||||
|
2020
Q3 | $138K | Buy |
|